Inhaled Sodium Cromoglycate for Cough in Lung Cancer Patients
Author Information
Author(s): M Moroni, C Portal, G Gualtieri, G Nastasil, C Tinelli
Primary Institution: IRCCS Policlinico San Matteo, Universita di Pavia
Hypothesis
Inhaled sodium cromoglycate might be effective in lung cancer patients who presented with irritative neoplastic cough.
Conclusion
Inhaled sodium cromoglycate can significantly reduce cough in non-small-cell lung cancer patients.
Supporting Evidence
- Cough is a common symptom in lung cancer patients, affecting about 71% of those with unresectable disease.
- Sodium cromoglycate treatment caused no acute side effects and was well accepted by patients.
- Cough intensity scores showed a significant reduction in the sodium cromoglycate group compared to placebo.
Takeaway
This study found that a medicine called sodium cromoglycate can help people with lung cancer who have a bad cough.
Methodology
Twenty non-small-cell lung cancer patients were randomized in a double-blind trial to receive either inhaled sodium cromoglycate or placebo, and cough severity was recorded daily.
Limitations
The study had a small sample size, which limits the strength of the conclusions.
Participant Demographics
10 males and 10 females, average age 64.2 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website